Research Groups and R&D Platforms: Assay development
Research Group:
Pharmacology of GABA(A) receptor subtypes
Mikko Uusi-Oukari
mikuus[at]utu.fi
Institute of Biomedicine,
University of Turku
Antibodies, Assay development, Basic research, Drug target, Fluorescence spectroscopy, Medicinal chemistry, Molecular modelling, Natural products, Neurological disorders, Organic compounds, Pharmacology, Polymorph analysis, Receptor, Signaling, Synthetic chemistry, Target discovery
Research Group:
Cancer Cell Signaling
Jukka Westermarck
jukwes[at]utu.fi
Turku Bioscience Centre and Institute of Biomedicine,
University of Turku
Assay development, Basic research, Biochemistry, Biomarker, Biomedicine, Breast cancer, Cancer, Colorectal cancer, Data mining, Diagnostics, Disease models, Drug delivery, Genomics, Lung cancer, Molecular Biology, Molecular Cell Biology, Nanoparticles, Next-generation sequencing, Pathology, Personalized medicine, Prostate cancer, Proteomics, Receptor, Screening, Signaling, Squamous cell carcinoma, Systems Biology, Target discovery, X-ray crystallography
Research Group:
Radiopharmaceuticals for positron emission tomography (PET) imaging
Xiang-Guo Li
xiali[at]utu.fi
Turku PET Centre,
University of Turku
Antibodies, Assay development, Biomedicine, Cancer, Cardiovascular diseases, Clinical Chemistry, Drug delivery, Drug solubility, Drug stability, Formulation, Imaging, In Vivo Diagnostics, Infection, Inflammation, Medicinal chemistry, Metabolic diseases, Molecular diagnostics, Nanoparticles, Nucleic acids, Organic Chemistry, Organic compounds, Personalized medicine, PET, Pharmacy, Physico-chemical properties, Preclinical development, Synthetic chemistry
Research Group:
Tissues Regeneration and Cancer
Fang Cheng
fang.cheng[at]utu.fi
Turku Bioscience Centre,
University of Turku
Assay development, Biomarker, Biomedicine, Biotechnology, Cancer, Colorectal cancer, Disease models, Drug target, High throughput imaging, Imaging, Inflammation, Lead optimization, Metabolic diseases, Molecular Cell Biology, Natural Compounds, Personalized medicine, Screening, Signaling, Skin diseases, Target discovery
Research Group:
Glycolipids and glycoproteins as cell adhesion receptors
Sauli Haataja
sauli.haataja[at]utu.fi
Institute of Biomedicine,
University of Turku
Antibacterial, Antibodies, Assay development, Bacteriology, Basic research, Biochemistry, Bioinformatics, Biomedicine, Biomolecular chemistry, Biopharmaceuticals, Biotechnology, Cancer, Electron microscopy, Genetics, Genomics, Imaging, Infection, Inflammation, Molecular Biology, Molecular Cell Biology, Molecular modelling, Nanoparticles, Natural Compounds, Natural products, Next-generation sequencing, Proteomics, Receptor, Screening, Signaling, Structural Biology, Synthetic chemistry, Systems Biology, Target discovery, X-ray crystallography
Research Group:
Viruses in the development of chronic lung diseases
Tytti Vuorinen
tytti.vuorinen[at]utu.fi
Institute of Biomedicine,
University of Turku
Allergy, Assay development, Asthma, Clinical Medicine, Disease models, Genomics, In Vitro Diagnostics, Infection, Inflammation, Molecular diagnostics, Point of care, Virology
